Find News

Filter articles

Applied Filters

Showing 1 to 10 of 2096 results

Azurity hits manufacturer with suit over hypertension drug patents

US28-10-2021Muireann Bolger

Azurity Pharmaceuticals has sued Florida-based generic manufacturer CoreRx for infringing a pair of patents covering a hypertension drug for children.

St Jude recovers partial attorney fees in heart catheter case

US26-10-2021Muireann Bolger

St Jude Medical will be able to claw back some of the attorney fees and expenses it incurred defending a suit filed by Niazi Licensing Corporation in a dispute over a patent covering a heart catheter.

Bausch & Lomb looks to protect patents in eyedrop lawsuit


Bausch & Lomb has accused a Nashville-based ophthalmic company of infringing two patents covering its eye-brightening drops, Lumify.

Kilpatrick Townsend expands patent litigation team

US21-10-2021Muireann Bolger

Law firm Kilpatrick Townsend & Stockton has announced the addition of Stuart Pollack to the firm’s New York office as a partner on the patent litigation team.

Big pharma supports Apple health sensor en banc bid

US19-10-2021Muireann Bolger

Apple has secured the backing of a major pharmaceutical industry trade association, as it seeks to persuade the US Court of Appeals for the Federal Circuit to revisit a case centring on a pair of health sensor patents.

Globus launches patent suit over spinal implant tech

US14-10-2021Muireann Bolger

Medical device company, Globus Medical, has filed a lawsuit against competitor Life Spine, alleging infringement of seven different patents related to spinal tech implant technology.

LSPN Live: ‘Unimpressive’ Arthrex remedy fuels uncertainty

US07-10-2021Muireann Bolger

The unpredictable nature of the US legal landscape has arguably kept IP practitioners on tenterhooks over the past decade.

Eleventh Circuit finds FDA fell foul of Orphan Drug Act


The US Court of Appeals for the Eleventh Circuit has found that the US Food and Drug Administration violated the exclusivity of a patent covering a drug for a rare autoimmune disorder, by approving the same treatment specifically for children.

BMS sues over generic of blockbuster leukaemia treatment

US04-10-2021Muireann Bolger

Bristol-Myers Squibb has sued India-based generic maker Alembic over claims that a copycat of the blockbuster leukaemia drug Sprycel, infringes a pair of patents.

Buyers of Zetia seek class recertification after 4th circ ruling

US28-09-2021Alex Baldwin

Wholesale buyers of MSD’s cholesterol treatment Zetia have asked a Virginia court to recertify their class status and move to trial following a recent fourth circuit ruling that reversed the court’s prior certification.

Showing 1 to 10 of 2096 results